scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education
BT Golf banking economy summit BT 500
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Samrat Pharmachem Ltd

Feedback
Samrat Pharmachem Ltd

Samrat Pharmachem Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 930
Jan 03, 2025 00:00 IST-
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹399.20
₹-5.60 (-1.38%)
    Powered By :
₹394 Low
Today’s Performance
₹414 High
₹320 Low
52 Week’s Performance
₹646 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -1.38%
  • 1 Week 3.58%
  • 1 Month 2.06%
  • 3 Months -30.39%
  • 6 Months 19.24%
  • 1 Year 4.69%
  • 3 Years 3.89%
  • 5 Years 33.54%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.61
  • 52-Week Low (₹) 320.00
  • 52-Week High (₹) 646.00
  • Price-to-Book (X)* 1.78
  • Dividend Yield (%) 0.25
  • Price-to-Earnings (P/E) (X)* 19.07
  • Earnings Per Share (₹) 20.93
  • Sector Price Earning (X)* 38.27
  • Market Cap (₹ Cr.)* 123.35
  • * Vaues as of last close price

COMPETITORS

BT TV

Mutual Funds 2025, Top Investments, Personal Finance, Mutual Fund Advice, Investment Tips, Business News 2:13 Beat The Market In 2025: Expert-Recommended Top Mutual Fund Schemes You Shouldn’t Miss!
Savers To Investors | Kotak Mahindra Bank CEO Ashok Vaswani On India’s New Investor Mindset 3:13 Savers To Investors | Kotak Mahindra Bank CEO Ashok Vaswani On India’s New Investor Mindset
Samir Arora On Why HDFC Bank Continues To Be A Key Stock In Portfolios 2:00 Samir Arora On Why HDFC Bank Continues To Be A Key Stock In Portfolios
Axis Bank’s Neelkanth Mishra Says The Indian Economy Is On The Mend Again 3:00 Axis Bank’s Neelkanth Mishra Says The Indian Economy Is On The Mend Again
IPO Market In 2025: Can Investors Expect Big Gains In The New Year? 2:25 IPO Market In 2025: Can Investors Expect Big Gains In The New Year?
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Sep 09, 2024 Sell
GOLECHHA GLOBAL FINANCE LIMITED
  • Qty 16000
  • Average Price ₹426.16
Aug 07, 2023 PURCHASE
SETU SECURITIES PVT. LTD.
  • Qty 15602
  • Average Price ₹344.43
Aug 07, 2023 Sell
ALERT CONSULTANTS & CREDIT PRIVATE LIMITED
  • Qty 21769
  • Average Price ₹345.74
Aug 07, 2023 Sell
SETU SECURITIES PVT. LTD.
  • Qty 15602
  • Average Price ₹341.65
Jul 27, 2023 Sell
GOLECHHA GLOBAL FINANCE LIMITED
  • Qty 23630
  • Average Price ₹405.82
Aug 18, 2022 PURCHASE
HARISHKUMARGUPTA
  • Qty 22000
  • Average Price ₹629.20
Jan 10, 2022 Sell
MALA R BHAVNANI
  • Qty 28294
  • Average Price ₹454.53
Jan 07, 2022 Sell
MALA R BHAVNANI
  • Qty 78000
  • Average Price ₹404.45
Jan 07, 2022 PURCHASE
ADVANI PRIVATE LIMITED
  • Qty 68000
  • Average Price ₹404.22
Dec 23, 2021 PURCHASE
TINA GOYAL
  • Qty 18800
  • Average Price ₹322.52
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Samrat Pharmachem Ltd share price previously?
Samrat Pharmachem Ltd share price was down by -1.38% from the previous closing price of ₹404.80.
Who are peers of Samrat Pharmachem Ltd?
The peers of Samrat Pharmachem Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Mankind Pharma Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Samrat Pharmachem Ltd?
The promotor/promotors of Samrat Pharmachem Ltd are Lalit Mehta, Rajesh Mehta, Renu P Dharod, Megh Mehta, Nishant Kankaria.
What has been 52-week high of Samrat Pharmachem Ltd stocks?
The highest price of Samrat Pharmachem Ltd stock is ₹646.00 in the last 52-week.
What is the share price of Samrat Pharmachem Ltd () today on BSE?
As on Jan 03, 2025, Samrat Pharmachem Ltd ()’s share price on BSE is Rs 399.2
What is the market cap of Samrat Pharmachem Ltd (?)
The current market capitalisation of Samrat Pharmachem Ltd () is 123.35 crores
What is Samrat Pharmachem Ltd Share symbol?
The symbol of Samrat Pharmachem Ltd is .
What is the PE ratio of Samrat Pharmachem Ltd ()?
The current PE ratio of Samrat Pharmachem Ltd () is 19.07.
What is the PB ratio of Samrat Pharmachem Ltd ()?
The current PB ratio of Samrat Pharmachem Ltd () is 1.78.
Today’s High & Low share prices of Samrat Pharmachem Ltd () on BSE?
Today, the share price of Samrat Pharmachem Ltd () on BSE touched a high of Rs 414 and a low of Rs 394
What price did Samrat Pharmachem Ltd () shares open on the BSE today?
On BSE, the share price of Samrat Pharmachem Ltd () opened at Rs 414
What is the 52-week high of Samrat Pharmachem Ltd ()?
The 52-week high price of Samrat Pharmachem Ltd () is Rs 646
What is the 52-week low of Samrat Pharmachem Ltd () ?
The 52-week low price of Samrat Pharmachem Ltd () is Rs 320

ABOUT SAMRAT PHARMA

Samrat Pharmachem Ltd, incorporated in the year 1992, has its registered office in Plot No A2/3445, GIDC Phase IV, Ankleshwar, Gujarat, 393002, 91-2646-220774, 91-2646-251291. The main industry in which Samrat Pharmachem Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Samrat Pharmachem Ltd is/are Shah & Savla LLP. In the main management, Lalit Mehta is chairman and Nishant Kankaria is the company secretary for Samrat Pharmachem Ltd.

  • LM Lalit Mehta Chairman & Managing Director
  • RM Rajesh Mehta Director & CFO
  • RPD Renu P Dharod Independent Director
  • MM Megh Mehta Executive Director
  • NK Nishant Kankaria Company Sec. & Compli. Officer

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement